Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors

Clinical trial NCT00983398 · UNKNOWN

Trial details

NCT number: NCT00983398
Sponsor: OHSU Knight Cancer Institute
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Central Nervous System Embryonal Neoplasm Embryonal Tumor With Multilayered Rosettes, C19MC-Altered Germ Cell Tumor Medulloblastoma Medulloepithelioma Primitive Neuroectodermal Tumor Recurrent Childhood Central Nervous System Embryonal Neoplasm Recurrent Malignant Germ Cell Tumor Recurrent Medulloblastoma Recurrent Primitive Neuroectodermal Tumor

Start date: 2009-07-09
Primary completion: 2021-12-31
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.